Eton Pharmaceuticals Inc (ETON)
3.67
+0.22
(+6.22%)
USD |
NASDAQ |
May 01, 16:00
3.67
0.00 (0.00%)
After-Hours: 20:00
Eton Pharmaceuticals Debt to Equity Ratio: 0.3476 for Dec. 31, 2023
Debt to Equity Ratio Chart
Historical Debt to Equity Ratio Data
| Date | Value |
|---|---|
| December 31, 2023 | 0.3476 |
| September 30, 2023 | 0.3396 |
| June 30, 2023 | 0.3643 |
| March 31, 2023 | 0.5734 |
| December 31, 2022 | 0.4907 |
| September 30, 2022 | 0.5711 |
| June 30, 2022 | 0.48 |
| March 31, 2022 | 0.4731 |
| December 31, 2021 | 0.3789 |
| September 30, 2021 | 0.4241 |
| Date | Value |
|---|---|
| June 30, 2021 | 0.3258 |
| March 31, 2021 | 0.3284 |
| December 31, 2020 | 0.4497 |
| September 30, 2020 | 5.048 |
| June 30, 2020 | 0.7037 |
| March 31, 2020 | 0.4303 |
| December 31, 2019 | 0.4303 |
| September 30, 2019 | 0.00 |
| June 30, 2019 | 0.00 |
| March 31, 2019 | 0.00 |
Debt to Equity Ratio Definition
The debt to equity ratio measures the (Long Term Debt + Current Portion of Long Term Debt) / Total Shareholders' Equity. This metric is useful when analyzing the health of a company's balance sheet.
Debt to Equity Ratio Range, Past 5 Years
--
Minimum
Jun 2019
5.048
Maximum
Sep 2020
0.64
Average
0.4303
Median
Dec 2019
Debt to Equity Ratio Benchmarks
| Evoke Pharma Inc | -1.938 |
| Outlook Therapeutics Inc | -- |
| NovaBay Pharmaceuticals Inc | 0.3431 |
| Palatin Technologies Inc | 0.00 |
| iBio Inc | -- |
Debt to Equity Ratio Related Metrics
| Total Assets (Quarterly) | 31.74M |
| Total Liabilities (Quarterly) | 16.26M |
| Shareholders Equity (Quarterly) | 15.48M |
| Current Ratio | 1.652 |
| Net Debt Paydown Yield | 0.18% |